uniQure N.V.
XNAS:QURE
26.45
$26.99 - 1,000.00
$26.13 - 10.00
$26.13
$26.95
$26.48
$27.51
71.5
5.89
1333340
1928647.1
56767039.25
Chart
TendieTensor AI Analysis
Company
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Fundamentals
209
-6.270000
7.476340
-1.38
100
54.87M
61.60M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own QURE. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.